Pharmaceutical Companies Relying on Pediatric Exclusivity to Drug Lifecycle

Pharmaceutical portfolio management teams have increasingly turned to pediatric extension strategies to extend their brands’ lifecycles and net a high rate of return, according to a recent study by Cutting Edge Information. Line extension …

Share